» Articles » PMID: 33494476

The Search for Biomarkers in Fibromyalgia

Overview
Specialty Radiology
Date 2021 Jan 26
PMID 33494476
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Fibromyalgia is the most common of the central sensitivity syndromes affecting 2-5% of the adult population in the United States. This pain amplification syndrome has enormous societal impact as measured by work absenteeism, decreased work productivity, disability and injury compensation and over-utilization of healthcare resources. Multiple studies have shown that early diagnosis of this condition can improve patient outlook and redirect valuable healthcare resources towards more appropriate targeted therapy. Efforts have been made towards improving diagnostic accuracy through updated criteria. The search for biomarkers for diagnosis and verification of Fibromyalgia is an ongoing process. Inadequacies with current diagnostic criteria for this condition have fueled these efforts for identification of a reproducible marker that can verify this disease in a highly sensitive, specific and reproducible manner. This review focuses on areas of research for biomarkers in fibromyalgia and suggests that future efforts might benefit from approaches that utilize arrays of biomarkers to identify this disorder that presents with a diverse clinical phenotype.

Citing Articles

Fibromyalgia and Inflammation: Unrevealing the Connection.

Garcia-Dominguez M Cells. 2025; 14(4).

PMID: 39996743 PMC: 11853252. DOI: 10.3390/cells14040271.


Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia.

Ayoub S, Ahmed A, Abdelwahed M, Khalefa A, Awaji A, Zekry S Eur J Med Res. 2025; 30(1):85.

PMID: 39920875 PMC: 11803959. DOI: 10.1186/s40001-025-02330-y.


Perceived and endocrine acute and chronic stress indicators in fibromyalgia syndrome.

Beiner E, Hermes M, Reichert J, Kleinke K, Vock S, Loffler A Sci Rep. 2024; 14(1):30471.

PMID: 39681564 PMC: 11649902. DOI: 10.1038/s41598-024-76635-z.


Unraveling Shared Diagnostic Biomarkers of Fibromyalgia in Ankylosing Spondylitis: Evidence from Comprehensive Bioinformatic Analysis and Experimental Validation.

Bi W, Yang M, Mao R J Inflamm Res. 2024; 17:6395-6413.

PMID: 39310900 PMC: 11415292. DOI: 10.2147/JIR.S474984.


Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies.

Jurado-Priego L, Cueto-Urena C, Ramirez-Exposito M, Martinez-Martos J Biomedicines. 2024; 12(7).

PMID: 39062116 PMC: 11275111. DOI: 10.3390/biomedicines12071543.


References
1.
Martinez J, Ferraz M, Sato E, Atra E . Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol. 1995; 22(2):270-4. View

2.
Hackshaw K, Rodriguez-Saona L, Plans M, Bell L, Buffington C . A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders. Analyst. 2013; 138(16):4453-62. DOI: 10.1039/c3an36615d. View

3.
Ang D, Moore M, Hilligoss J, Tabbey R . MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study. Pain Med. 2011; 12(8):1154-61. DOI: 10.1111/j.1526-4637.2011.01179.x. View

4.
Lindh M, Johansson G, Hedberg M, Henning G, Grimby G . Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol. 1995; 24(1):34-7. DOI: 10.3109/03009749509095152. View

5.
Petzke F, Clauw D, Ambrose K, Khine A, Gracely R . Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain. 2003; 105(3):403-413. DOI: 10.1016/S0304-3959(03)00204-5. View